- Sitemap
Sitemap
- News
- Announcements
- FoundationOne®CDx: genetic profiling of solid tumours
- Evaluation of individual medical procedures 2014 - Reports
- Transparency: Sponsoring of patient initiatives, Update
- (Good) practice organizational models using real-world evidence for public funding of high prized therapies
- >=12 Month Follow-Up of Patients with Spinal Muscular Atrophy (SMA) treated with Spinraza®, Zolgensma® or Combination Therapies
- Acupuncture - areas of application, current evidence and proven indications
- Advanced Therapy Medicinal Products (ATMP): Technology forecast
- Announcement
- Annual Report 2013 online
- Annual Report 2014 online
- Annual Report 2015 online
- Annual Report 2016 online
- Annual Report 2017 online
- Annual Report 2018 online
- Annual Report 2020 online
- Artificial Intelligence in health care with a focus on hospitals: Methodological considerations for Health Technology Assessment. A Scoping Review.
- Assessment – APPRAISAL – Decision: (Good) Practice examples and recommendations
- ATMPs and Gene Therapies in Development. Horizon Scanning – Update 2022
- Background Analysis for National HTA Strategy for Lithuania: Focus on Medical Devices
- Balloon Eustachian Tuboplasty for the treatment of Eustachian tube dysfunction - German short version and update of the correspondent EUnetHTA assessment
- Bamlanivimab monotherapy and as combination therapy (with etesevimab) for Covid-19
- Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenosis
- Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease)
- C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections
- CAR-T cell therapy: Contrasting the evidence from pivotal trials with the real world evidence (RWE)
- CAR-T Cell-Therapies in Development, Update 2022
- CAR-T Celltherapies, ATMPs and Gene Therapies in Development, Horizon Scanning
- Carbon ion beam radiotherapy (CIRT) for cancer treatment: a systematic review of effectiveness and safety for 12 oncologic indications.
- Cervical cancer screening: p16/KI-67 Dual Stain test (CINtec® PLUS) in the triage of equivocal results or mild to moderate dysplasia in pap cytology
- Cervical Carcinoma Prevention - Implementation of an HPV screening test in the early detection of cervical cancer in Austria
- Child and adolescent mental health care models
- Claudia Wild of the Ludwig Boltzmann Institute Health Technology Assessment in Expert Panel of the European Commission
- Combinationtherapy Casirivimab plus Imdevimab (REGN-COV2) for the treatment of covid-19
- Costs of day surgery in Austria: An analysis of data and methods for varicose vein surgery as an example
- Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020), Report & Appendix
- Covid-19: HSS/ Horizon Scanning Living Document (v02 May 2020)
- Covid-19: HSS/ Horizon Scanning Living Document (v03 June 2020)
- Covid-19: HSS/ Horizon Scanning Living Document (v04 July 2020), Report & Appendix
- Covid-19: HSS/ Horizon Scanning Living Document (v05 August 2020)
- Covid-19: HSS/ Horizon Scanning Living Document (v06 September 2020)
- Covid-19: HSS/ Horizon Scanning Living Document (v07 October 2020)
- Covid-19: HSS/ Horizon Scanning Living Document (v08 November 2020)
- Covid-19: HSS/ Horizon Scanning Living Document (v09 December 2020)
- Covid-19: HSS/ Horizon Scanning Living Document (v10 January 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v11 February 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v12 March 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v13 April 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v14 May 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v15 June 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v16 July 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v17 August/September 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v18 October/November 2021)
- Covid-19: HSS/ Horizon Scanning Living Document (v19 December 2021/January 2022)
- Covid-19: HSS/ Horizon Scanning Living Document (v20 February/ March 2022)
- Covid-19: HSS/ Horizon Scanning Living Document (v21 April/ May 2022)
- Covid-19: HSS/ Horizon Scanning Living Document (v22 June/July2022)
- Covid-19: HSS/ Horizon Scanning Living Document (v23 August/September2022)
- Covid-19: HSS/ Horizon Scanning Living Document (v24 October/November2022)
- Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
- Dropouts in Psychotherapy
- Drug reimbursement in the inpatient sector in Austria: Approaches for a transparent and evidence-based process taking into account international experience
- Drugs in Oncology: an overview of benefit and refund practices in Europe
- Echocardiography: Guideline recommendations and options to identify inappropriate use as well as rate of use in Austria.
- Economic Dimensions of Community Nursing: A Systematic Literature Review
- Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia
- Effects of tangible and intangible incentives on health behavior, Part I: Definitions, theories and models – Part II: Overview of reviews covering 4 health issues
- Epidemiology of long COVID: a preliminary report. German short version of the original KCE report
- Evaluation methods for the benefit assessment of easily accessible, out-patient health centers for vulnerable groups - Target group focus: Homeless and non-insured people
- Evaluation of individual medical procedures - Reports 2020
- Evaluation of individual medical procedures - Reports 2021
- Evaluation of individual medical procedures - Reports 2022
- Evaluation of individual medical procedures - Reports 2023
- Evaluation of individual medical procedures - Reports 2024
- Evaluation of individual medical procedures 2015 - Reports
- Evaluation of individual medical procedures 2016 - Reports
- Evaluation of individual medical procedures 2017 - Reports
- Evaluation of individual medical procedures 2018 - Reports
- Evaluation of individual medical procedures 2019 - Reports
- Evidence requirements for the authorization and reimbursement of high-risk medical devices in the USA, Europe, Australia and Canada: An analysis of seven high-risk medical devices
- External stimulation of the trigeminal nerve for the prevention and acute treatment of episodic and chronic migraine
- Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples
- Genetic Testing in the Context of Familial Hypercholesterolaemia Management
- Hadron therapy in children: evidence synthesis for 15 paediatric tumours. Report based on Belgian (KCE) HTA report
- Hadron Therapy: Proton and carbon ion therapy - a review on clinical evidence of efficacy, ongoing research and reimbursement
- Health Services Research in Oncology Part I: End-of-Life Care
- Health Services Research in Oncology: Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Therapy in Real-World Practice
- Health Services Research in Oncology: Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Therapy in Real-World Practice. A Pilot Project in Cooperation with Tirol Kliniken GmbH & KAGes
- Health Technology Assessments on Medical Devices in Europe
- Hepatitis C virus screening in hospitals
- Home-Treatment in Child and Adolescent Psychiatry: An Analysis of the Effectiveness and Possible Implementation in Austria
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Fact Sheets
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology - Reports
- Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning in Onkology - Reports
- Horizon Scanning of Medicines - Fact Sheets
- Horizon Scanning of Medicines - Fact Sheets
- Horizon Scanning of Medicines - Fact Sheets
- Horizon Scanning of Medicines - Fact Sheets
- HTA-Strategy for Lithuania
- Identification of ineffective interventions and technologies Existing models and their implementation
- Image-guided spinal injections in treatment of chronic spinal pain: an overview of evidence-based guideline recommendations and specific focus on guidance techniques
- Inhalation sedation with laughing gas (N2O) in dentistry – organisational and professional aspects and a systematic review of efficacy and safety
- Involvement of Citizen and Patients in HTA-Processes – International Experiences and Good Practice Examples
- Irreversible electroporation for the treatment of liver and pancreatic cancer
- Long COVID care pathways and structures: an updated scoping review
- Long COVID care pathways: a systematic review
- Lung cancer screening in risk groups
- Lung Cancer Screening in Risk Groups: A Review-Update of the Economic Evidence (Part II)
- MammaPrint® Added value of using the gene expression signature test MammaPrint® for adjuvant chemotherapy decision-making in early breast cancer. EunetHTA report
- Mechanical thrombectomy devices for acute ischemic stroke: German version of the English EUnetHTA report
- Mental Health Rehabilitation for Children and Adolescents – Systematic overview of evaluation outcomes and instruments
- Mental health screening of adults in primary care
- Minimum volume standards for quality assurance in day surgery
- Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
- National strategies and programmes for preventing and managing non-communicable diseases in selected countries
- New HTA-teaching and practice book
- Nivolumab in malignant melanoma: contrasting the evidence from the pivotal trials with the real world evidence (RWE)
- Non-interventional studies (NIS) in Austria, 2nd update of systematic analyses 2016 & 2017
- Non-interventional studies (NIS) in Austria. A systematic analysis.
- Occupational therapy in children and adolescents. Literature review on indications, utilisation and recommendations
- Oncological Breast Cancer Care in Selected European Countries- Cross-sectoral cancer care models
- Opportunities and strategies to drive appropriate use of MRI in Austria
- Opportunities and strategies to drive appropriate use of MRI in Austria. Part 2
- Options to identify inappropriate use of MRI, Part 3
- Oral and parenteral preexposure prophylaxis (PrEP) to prevent HIV in people at risk: a systematic review of clinical effectiveness and safety with assessment of organisational, economic, patients/social, ethical and legal elements
- Osteopathy: effectiveness and safety for musculoskeletal pain and overview of training and quality requirements
- Outpatient cardiac rehabilitation part VI: prospective multi-centre cohort study (comparing patients with and without phase III)
- Outpatient cardiac rehabilitation. Part VII: economic evaluation
- Outpatient neurological rehabilitation: goal attainment in stroke patients. Systematic review.
- Parent-Child-Pass Update 2020/21 – Screenings for mental health, nutrition and social competence – recommendations from evidence-based guidelines
- Percutaneous aortic valve replacement in Austria (Part II): Data analysis
- Perinatal and infant mental health care in Austria: A mapping of existing prevention, screening and care structures, with a specific focus on Tyrol
- Perinatal and infant mental health care models and pathways
- Perinatal Care at the threshold of viability Part II: Decision-making at the threshold of viability and ethical challenges at Neonatal Intensive Care Units (NICUs)
- Perinatal care at the threshold of viability; Part I: Systematic Analysis of Outcomes and Resource Needs for Neonatal Intensive Care Units to inform Healthcare Planning
- PET/PET-CT Evidence for need based planning (in oncology indications)
- PET/PET-CT Evidence for need based planning in Germany and Austria
- Pharma: Disclosure of payments in Austria 2015
- Pharma: Disclosure of transfers of value in austria 2018. Update of the systematic analysis 2015
- POCT/ Point of Care Tests: D-Dimer and Troponin
- Point of Care Tests (POCT): D-Dimer and Troponin. Update 2024
- Prevalence of mental disorders and uptake of mental health services in Tyrol: An analysis of epidemiological literature and administrative data from the Tyrolean health insurance
- Procedural guidance for the systematic evaluation of biomarker tests
- Process and evaluation of digital health applications in the context of “symptom-checkers”
- Proton and carbon ion therapy – an update on indications
- Psychotherapy - concepts, effect factors and a German-speaking country comparison of legal regulations
- Quality Registries in Dementia Care: Mapping of Registries to improve Quality and Service Delivery
- Re-orientation of the Austrian parent-child preventive care programme Part X: further development of the mother-child-pass. Scientific support of the appraisal process
- Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
- Re-orientation of the Austrian parent-child preventive care programme. Part XII: Economic evaluation of selected screenings during pregnancy
- Registries in Austria and their utilisation for healthcare improvement
- Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries
- Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
- Research interests of Non-interventional studies (NIS) in Austria. Update of the systematic analysis.
- Risk-based breast cancer screening in Austria: a systematic analysis of predictive models to assess individual breast cancer risk, their utility and applicability in a breast cancer screening program
- Robot-assisted surgery in thoracic and visceral indications
- Robot-assisted surgery in thoracic and visceral indications – Update 2023
- Robot-assisted surgery: A systematic review of effectiveness and safety for elected indications and accumulating costs
- Robotics and functional electrical stimulation for stroke rehabilitation
- Role of Public Contributions to the Development of Health Innovations
- Screening and prevention programmes for children and adolescents from 6 to 14 years
- Screening for Diabetes mellitus: guideline recommendations
- Screening for fetal trisomies 21, 18 and 13 by non-invasive prenatal testing (NIPT). EUnetHTA report
- Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
- Screening, diagnostics and indication for occupational therapy in children and adolescents with Developmental Coordination Disorder
- SMA therapies: Mid-to-long-term follow-up of patients treated >=24 months with nusinersen or onasemnogene abeparvovec, and >=12 months with risdiplam (mono/combination therapy)
- Social Return on Investment: Outcomes, Methods, and Economic Parameters
- Sponsoring Austrian CME/ continuing medical education for physicians. A systematic analysis of the CME-Database
- Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
- Sponsoring of patient initiatives in Austria.5th Update of the Systematic Analyses 2014 to 2019
- Sponsoring of Patientinitiatives in Austria 2015. Update of the Systematic Analysis 2014
- Sponsoring of Patientinitiatives in Austria 2016. Update of the Systematic Analyses 2015 and 2014
- Sponsoring of Patientinitiatives in Austria. Systematic Analysis
- Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
- Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localized prostate cancer
- Stool DNA testing for colorectal cancer (CRC) screening
- Strategies for recruitment and programme adherence in group programmes for children, adolescents and adults with overweight and grade 1 obesity
- Strategies for reducing weight stigmatisation towards people with overweight or obesity in the healthcare system
- Supply mandates
- Supporting children who have parents with mental disorders in Tyrol: A mapping of existing Tyrolean support and societal structures
- Sustainability of inpatient psychiatric rehabilitation for adults: systematic review
- Telemonitoring in Austrian diabetes care: A systematic analysis of evaluation methodologies
- The economic and societal dimension of parental mental illness
- Threshold values in health economic evaluations and decision-making
- Thrombectomy for ischemic stroke: Patient characteristics, structural requirements and (differential) diagnostics
- Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
- Transcatheter Aortic Valve Implantation Part I: A systematic review of health economic evaluations
- Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (Mitraclip®, Carillon®, NeoChord DS1000)
- Treatment by clinical psychologists: Literature overview on training, methods of treatment and areas of application
- Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents aged 6 years and more
- Update PET/PET-CT evidence for need based planning in the area of oncology
- Update PET/PET-CT evidence for need based planning in the area of oncology
- Update Re-orientation of the Austrian parent-child preventive care programme Part IX: Recommendations from evidence-based guidelines for screening measures covering early childhood (0-6 yrs.)
- Uptake of Mental Health Benefits in Women Before and During the Perinatal Period: An Analysis of Austrian Health Insurance Data
- Vaccination against human papillomavirus (HPV). Decision-aid for young women and girls
- Vasoprotectives: Efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoidal diseases
- Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022
- Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
- Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Updtae 2018
- Zostavax® for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA Core Model for Rapid Relative Effectiveness Assessment. Pilot-ID: WP-SA-1
- FoundationOne®CDx: genetic profiling of solid tumours
- Events
- Newsletter
- Press release on our reports
- Press photos
- Announcements
- About us
- Evaluation
- History
- Methods
- Team
- Claudia Wild
- Ingrid Zechmeister-Koss
- Karin Hutterer-Schubert
- Smiljana Blagojevic
- Ozren Sehic
- Tarquin Mittermayr
- Judit Erdös
- Julia Mayer-Ferbas
- Nicole Grössmann-Waniek
- Sabine Ettinger
- Sarah Wolf
- Gregor Goetz
- Christoph Strohmaier
- Lucia Gassner
- Reinhard Jeindl
- Viktoria Hofer
- Daniel Fabian
- Julia Kern
- Michaela Riegelnegg
- Yui Hidaka
- Doris Giess
- Eleen Rothschedl
- Eva Malikova
- Jule Anna Pleyer, MSc, EMPH
- Louise Schmidt
- Claudia Wild
- Shareholder & organization chart
- Stakeholder involvement
- Press clippings
- Evaluation
- Research areas
- Research Projects
- Synopsis of current research projects
- Synopsis of completed research projects
- HTA-Information Service Rapid Reviews
- Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs
- Horizon Scanning of Medicines - Reports and Fact Sheets
- Horizon Scanning in Oncology – support for a budget-impact-calculation
- Evaluation of individual medical procedures - Reports
- All projects in an overview
- Synopsis of current research projects
- Publications
- Search
